Simó Rafael, Lecube Albert, Segura Rosa M, García Arumí José, Hernández Cristina
Division of Endocrinology, Diabetes Research Unit, Hospital General Universitari Vall d'Hebron, Barcelona, Spain.
Am J Ophthalmol. 2002 Sep;134(3):376-82. doi: 10.1016/s0002-9394(02)01538-6.
To investigate the relationship between insulin-like growth factor-I (IGF-I) and vascular endothelial growth factor (VEGF) in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy (PDR).
Observational case-control study.
In a prospective study, 37 consecutive diabetic patients with PDR (14 type I and 23 type II diabetes mellitus) in whom a vitrectomy was performed were compared with 21 nondiabetic patients with other conditions requiring vitrectomy (control group). Free IGF-I and VEGF were measured by ELISA.
Vitreal levels of both free IGF-1 and VEGF were higher in diabetic patients with PDR than in control subjects (P <.01, and P <.0001, respectively). After adjusting for total intravitreous protein concentration, VEGF (ng/mg of proteins) remained significantly higher in diabetic patients with PDR than in the control group (P <.0001), whereas free IGF-I (ng/mg of proteins) was lower in diabetic patients than in control subjects (P <.0001). The vitreous concentrations of VEGF were higher in patients with active PDR than in patients with quiescent PDR (P <.005), whereas vitreous free IGF-I was not related to PDR activity. Finally, we did not observe a correlation between the vitreal levels of free IGF-I and VEGF.
We conclude that free IGF-I and VEGF are both increased, but not related, within the vitreous fluid of diabetic patients with PDR. In addition, our results support the current concept that VEGF is directly involved in the pathogenesis of PDR, whereas the precise role of free IGF-I remains to be established.
探讨增殖性糖尿病视网膜病变(PDR)糖尿病患者玻璃体液中胰岛素样生长因子-I(IGF-I)与血管内皮生长因子(VEGF)之间的关系。
观察性病例对照研究。
在一项前瞻性研究中,将37例连续接受玻璃体切除术的PDR糖尿病患者(14例I型糖尿病和23例II型糖尿病)与21例因其他情况需要接受玻璃体切除术的非糖尿病患者(对照组)进行比较。采用酶联免疫吸附测定法(ELISA)检测游离IGF-I和VEGF。
PDR糖尿病患者的玻璃体内游离IGF-1和VEGF水平均高于对照组(分别为P <.01和P <.0001)。调整玻璃体内总蛋白浓度后,PDR糖尿病患者的VEGF(每毫克蛋白中的纳克数)仍显著高于对照组(P <.0001),而糖尿病患者的游离IGF-I(每毫克蛋白中的纳克数)低于对照组(P <.0001)。活动期PDR患者的玻璃体内VEGF浓度高于静止期PDR患者(P <.005),而玻璃体内游离IGF-I与PDR活动无关。最后,我们未观察到游离IGF-I与VEGF的玻璃体内水平之间存在相关性。
我们得出结论,PDR糖尿病患者的玻璃体液中游离IGF-I和VEGF均升高,但两者无相关性。此外,我们的结果支持当前的观点,即VEGF直接参与PDR的发病机制,而游离IGF-I的确切作用仍有待确定。